Multicentre evaluation of artificial intelligence risk classification for detection of clinically significant prostate cancer on biparametric MRI - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Multicenter Assessment of AI-Based Risk Stratification for Identifying Clinically Relevant Prostate Cancer via Biparametric MRI

  • By

  • Karsten Guenzel

  • Maarten G. Poirot

  • Almar van Loon

  • Emanuele Messina

  • Martina Pecoraro

  • Valeria Panebianco

  • Robert Princenthal

  • Francesco Giganti

  • September 26, 2026

Share

Original Source(s)

Multicentre evaluation of artificial intelligence risk classification for detection of clinically significant prostate cancer on biparametric MRI

  • by Karsten Guenzel, Maarten G. Poirot, Almar van Loon, Emanuele Messina, Martina Pecoraro, Valeria Panebianco, Robert Princenthal, Francesco Giganti

  • September 26, 2026

Related Content

Malignant transformation of lower-grade glioma: contrast enhancement, extent of resection, and the natural history under interval-censored analysis

HHS and EPA Announce New Scientific Partnership to Strengthen Glyphosate Review

Correction to: Long-term results (> 12 years) of surgical treatment of perihilar cholangiocarcinoma: Application of a modified Nagoya approach at a western center